Generic sponsors could find more inactive ingredient and excipient information in reference product labels going forward as the US Food and Drug Administration looks for additional ways to speed drug competition to the market.
Center for Drug Evaluation and Research Director Patrizia Cavazzoni said the FDA’s inability to share the information makes complex generic...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?